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Up to 30% of women experience early miscarriage due to impaired decidualization.
For implantation to occur, the uterine endometrial stromal fibroblast-like cells must
differentiate into decidual cells, but the genes required for decidualization have not
been fully defined. Here, we show that Malignant Brain Tumor Domain-containing
Protein 1 (MBTD1), a member of the polycomb group protein family, is critical for
human endometrial stromal cell (HESC) decidualization. MBTD1 predominantly localized
to HESCs during the secretory phase and the levels were significantly elevated
during in vitro decidualization of both immortalized and primary HESCs. Importantly,
siRNA-mediated MBTD1 knockdown significantly impaired in vitro decidualization of
both immortalized and primary HESCs, as evidenced by reduced expression of the
decidualization markers PRL and IGFBP1. Further, knockdown of MBTD1 reduced cell
proliferation and resulted in G2/M cell cycle arrest in decidualizing HESCs. Although
progesterone signaling is required for decidualization, MBTD1 expression was not
affected by progesterone signaling; however, MBTD1 knockdown significantly reduced
expression of the progesterone target genes WNT4, FOXOA1, and GREB1. Collectively,
our data suggest that MBTD1 contributes to in vitro decidualization of HESCs by
sustaining progesterone signaling. This work could have implications for designing
diagnostic and therapeutic tools for recurrent pregnancy loss.
Keywords: decidualization, malignant brain tumor domain-containing protein 1 (MBTD1), progesterone,
endometrium, stromal cells, embryo implantation

INTRODUCTION
Approximately 30% of women experience early miscarriage due to defective decidualization. Many
of these miscarriages likely occur because the uterine endometrial stromal cells fail to transform
from fibroblastic stromal cells into epithelioid-like secretory decidual cells (Salker et al., 2010;
Teklenburg et al., 2010; Koot et al., 2012). To develop better diagnostic tools and treatment options
for women experiencing early miscarriages, we must fully define the mechanisms and proteins
required for decidualization.
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informed consent, and the research was approved by the
Washington University in St. Louis Institutional Review Board
(IRB ID #201612127) as described previously (Michalski et al.,
2018). Additionally, all work involving human subjects followed
the guidelines of the World Medical Association Declaration
of Helsinki. Endometrial biopsies from healthy women of
reproductive age were obtained during the proliferative phase
(days 9 to 12) of the menstrual cycle, and endometrial cells
were isolated as described previously (Camden et al., 2017;
Michalski et al., 2018). Briefly, endometrial biopsies were
minced using sterile scissors and then digested in DMEM/F12
media containing 2.5 mg/ml collagenase (Sigma-Aldrich, Saint
Louis, MO, United States) and 0.5 mg/ml DNase I (SigmaAldrich, St. Louis, MO, United States) for 1.5 h at 37◦ C.
Subsequently, detached cells were centrifuged and collected. The
cells were then layered over a Ficoll-Paque reagent layer (GE
Healthcare Biosciences, Pittsburgh, PA, United States) to remove
lymphocytes. The top layer, containing the HESC fraction, was
collected and filtered through a 40-µm nylon cell strainer (BD
Biosciences, Franklin Lakes, NJ, United States). The filtrate
containing HESCs was further resuspended in DMEM/F12 media
containing 10% fetal bovine serum (FBS), 100 U/ml penicillin,
and 0.1 mg/ml streptomycin and cultured in tissue culture flasks.
For each experiment, the total number of a minimum of three
HESC lines were used. Representative data are from one patient
sample experiment performed with three technical replicates.

Two key players in decidualization are the steroid hormones
estrogen and progesterone. The primary role of estrogen is to
prepare the uterine epithelia for embryo implantation. When
progesterone concentration increases, estrogen action is inhibited
in uterine epithelia, and endometrial stromal cell decidualization
initiates. Progesterone acts by binding progesterone receptors
and associated coregulators and subsequently activating
expression of genes (Rubel et al., 2010; Lonard and O’Malley,
2012; Hantak et al., 2014; Wang et al., 2017) such as FOXO1A,
WNT4, GATA2, and GREB1. However, it is likely that many
genes important for decidualization have not been identified.
Bian et al. showed that polycomb repressive complex 1
(PRC1) controls decidualization (Bian et al., 2016). Polycomb
group (PcG) proteins play important roles in development
through their ability to modify histones and thereby control
gene expression (Luo et al., 2013). Two PcG protein complexes,
PRC1 and polycomb repressive complex 2 (PRC2), regulate
chromatin remodeling and affect gene regulation (Levine et al.,
2002). The PcG protein malignant brain tumor domaincontaining protein 1 (MBTD1) regulates gene expression by
controlling the chromatin remodeling process. MBTD1 is also
a part of the histone acetyltransferase TIP60/NuA4 complex,
which participates in DNA double-strand breaks repair through
homologous recombination (Jacquet et al., 2016). Interestingly,
acting as histone modifiers, the PcG proteins regulate gene
transcription through methyltransferase activity (Mills, 2010)
and by modulating histone acetyltransferase activity of the
NuA4/TIP60 complex (Jacquet et al., 2016). Furthermore, histone
modifications have been shown to play an important role in
decidualization (Liu et al., 2019).
The MBTD1–CXorf67 fusion proteins have been observed
in cases of low-grade endometrial stromal sarcoma (Dewaele
et al., 2014). Further, analysis of publicly available GEO datasets
revealed distinct MBTD1 expression in endometrial tissue in both
physiological and pathological conditions, suggesting a possible
role for MBTD1 in endometrial function. Here, we demonstrate
that MBTD1 is upregulated during decidualization and plays
an important role in progesterone-driven human and mouse
endometrial stromal cell decidualization.

Cell Culture
Primary HESCs were maintained in DMEM/F12 media
supplemented with 10% FBS, 100 U/ml penicillin, and 0.1 mg/ml
streptomycin at 37◦ C and 5.0% CO2 concentration under
humid conditions. Experiments were performed using no
more than four passages. The telomerase-transformed human
endometrial stromal cells (T-HESCs) were purchased from
ATCC (ATCC CRL4003) and maintained in phenol-red free
DMEM/F12 medium with 3.1 g/L glucose and 1 mM sodium
pyruvate supplemented with 10% charcoal/dextran-treated FBS,
1% ITS (insulin, transferrin, sodium selenite + Premix, 1.5 g/L
sodium bicarbonate, and 500 ng/ml puromycin), 100 U/ml
penicillin, and 0.1 mg/ml streptomycin. The media was replaced
every other day.

MATERIALS AND METHODS
Ethical Approval for the Collection of
Endometrial Tissue

siRNA Transfection and in vitro
Decidualization

Endometrial tissue from women with regular menstrual cycles
were obtained under a protocol (IRB ID #201612127) approved
by the Washington University in St. Louis Institutional Review
Board and the guidelines of the Declaration of Helsinki
(Michalski et al., 2018). All subjects were recruited through
the Washington University online classified section and local
newspaper advertisements. Eligible participants signed an
Informed Consent and Authorization form.

HESCs were plated in 6-well cell culture plates and treated
in triplicate with Lipofectamine 2000 reagent (Invitrogen
Corporation, Carlsbad, CA, United States) and 60 pmol of
the following siRNAs: non-targeting siRNA/control siRNA (D001810-10-05) or siRNAs targeting MBTD1 (L-020603-00-005)
(GE Healthcare Dharmacon Inc., Lafayette, CO, United States) as
described previously (Camden et al., 2017). After 48 h, cells were
treated with decidualization media containing 100 nM estradiol
(cat. no. E1024, Sigma-Aldrich), 10 µM medroxyprogesterone
17-acetate (MPA) (cat. no. M1629, Sigma-Aldrich), and 50 µM
N6, 20 -O-dibutyryladenosine 30 ,50 -cyclic monophosphate sodium

Endometrial Stromal Cell Isolation
Primary human endometrial stromal cells (HESCs) were
obtained from patient donors. Patients provided written
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was collected at day 0 and 6 and stored at −80◦ C. According
to the manufacturer’s instructions, the Prolactin ELISA (cat.
no. EHIAPRL, Invitrogen) was performed in cell culture media.
Briefly, 50 µl of media was used to quantify the secreted
Prolactin protein, and concentration of Prolactin was calculated
from the standard curve. Each experiment was performed in
triplicate and repeated in three independent HESC lines isolated
from three subjects.

salt (cat. no. D0260, Sigma-Aldrich) in 1 × Opti-MEM reducedserum media containing 2% charcoal-stripped FBS (referred to as
EPC). The decidualization medium was changed every 48 h until
day 3 or day 6, when the cells were harvested for RNA isolation
with a total RNA isolation kit (Invitrogen/Life Technologies,
Grand Island, NY, United States).
For MPA time course experiments, HESCs were plated in
six-well cell culture plates and, at 80–90% confluence, were
treated with 1 µM MPA in 1 × Opti-MEM reduced-serum media
containing 2% charcoal-stripped FBS. Cells were harvested for
RNA isolation using a total RNA isolation kit (Invitrogen/Life
Technologies) or for protein collection using RIPA buffer
(cat. no. 9806, Cell Signaling Technology) containing 20 mM
Tris–HCl (pH 7.5), 150 mM NaCl, 1 mM Na2 EDTA, 1 mM
EGTA, 1% NP-40, 1% sodium deoxycholate, 2.5 mM sodium
pyrophosphate, 1 mM beta-glycerophosphate, 1 mM Na3 VO4 ,
1 µg/ml leupeptin, and 1 mM PMSF.

qRT-PCR
Cells or tissues were lysed in lysis buffer, and total RNA
was isolated with the Purelink RNA mini kit (Invitrogen)
according to the manufacturer’s instructions. RNA was quantified
with a Nano-Drop 2000 (Thermo Scientific, Waltham, MA,
United States). RNA (1 µg) was reverse transcribed with
the High-Capacity cDNA Reverse Transcription Kit (Thermo
Scientific). The amplified cDNA was diluted to 10 ng/µl,
and qRT-PCR was performed with primers specified in
Supplementary Table 1 and Fast Taqman 2 × mastermix
(Applied Biosystems/Life Technologies, Grand Island, NY,
United States) on a 7500 Fast Real-time PCR system (Applied
Biosystems/Life Technologies). The delta–delta cycle threshold
method was used to normalize expression to the reference gene
18S (Kommagani et al., 2013, 2016; Camden et al., 2017).

Cell Proliferation Assay
Cell proliferation was determined by performing the MTT
assay (Promega, Madison, WI, United States) according to the
manufacturer’s instructions. Briefly, HES cells were transfected
with non-targeting/control siRNA (D-001810-10-05), MBTD1
siRNA (L-020603-00-005), and PGR siRNA (L-006763-00-0005)
(GE Healthcare Dharmacon Inc., Lafayette, CO, United States)
and co-transfected with both MBTD1 and PGR siRNAs with
the aid of Lipofectamine 2000 reagent (Invitrogen Corporation,
Carlsbad, CA, United States). Then, 48 h post-transfection,
1 × 103 HESCs were plated per well of a 96-well plate
(in triplicate). After the attachment, cells were treated with
decidualization (EPC) media. The relative proliferation rate was
evaluated with the MTT proliferation kit at 0, 24, and 48 h. The
experiments were performed on three independent HESCs lines
with three technical replicates in each.

SDS-PAGE and Western Blotting

Forty-eight hours following siRNA transfection with control
siRNA or MBTD1 siRNA alone or PGR siRNA alone or
both MBTD1 and PGR siRNAs together using Lipofectamine
2000 transfection agent (Invitrogen Corporation, Carlsbad, CA,
United States), HESCs were trypsinized and counted. For flow
cytometry analysis, 2 × 105 cells were plated per well of sixwell plates and then were treated with decidualization (EPC)
media. After cells were cultured in EPC media for 48 h, cells were
trypsinized, washed with phosphate-buffered saline (PBS), fixed
in 70% chilled ethanol, and stained with 50 µg/ml propidium
iodide (Sigma-Aldrich, St. Louis, MO, United States) containing
50 µg/ml RNase. Cell cycle stage analysis was performed by
flow cytometry (FACS Canto II) and FACS Diva software (ver.
8.0; BD Biosciences, Franklin Lakes, NJ, United States). Each
experiment was performed in technical duplicates and repeated
in three independent HESC lines isolated from three subjects.

HESCs were homogenized in RIPA lysis buffer (cat. no. 9806,
Cell Signaling Technology) containing 20 mM Tris–HCl (pH
7.5), 150 mM NaCl, 1 mM Na2 EDTA, 1 mM EGTA, 1% NP40, 1% sodium deoxycholate, 2.5 mM sodium pyrophosphate,
1 mM beta-glycerophosphate, 1 mM Na3 VO4 , 1 µg/ml leupeptin,
and 1 mM PMSF and centrifuged at 14,000 × g for 15 min at
4◦ C to collect the supernatant containing total protein lysates.
Protein concentration was quantified using the BCA Protein
Assay kit (cat no. 23227, Thermo Scientific) according to the
manufacturer’s instructions. HESC lysate sample, containing
40 µg of protein, was loaded on a 4–15% SDS-polyacrylamide
gel, separated with 1 × Tris–Glycine running buffer, and
transferred to PVDF membranes using a wet electro-blotting
system (Bio-Rad, United States), according to the manufacturer’s
directions. PVDF membranes were blocked for 1 h in 5% nonfat milk in TBS-T (Bio-Rad) and incubated overnight at 4◦ C
with anti-MBTD1 (1:500, ab170848, Abcam) and anti-GAPDH
(1:3000, #2118S Cell Signaling Technology, United States) in
5% BSA in TBS-T. Blots were then probed with anti-rabbit
IgG conjugated with horseradish peroxidase (1:5000, #7074,
Cell Signaling Technology) in 5% BSA in TBS-T for 1 h at
room temperature. Signal was detected with the Immobilon
Western Chemiluminescent HRP Substrate (Millipore, MA,
United States), and blot images were collected with a Bio-Rad
ChemiDoc imaging system. Image Lab was used for densitometry
analysis of the blot.

Prolactin ELISA

Immunofluorescence

After 48 h of transfection with control or MBTD1 siRNA,
cells were treated with decidualization media, and media was
changed every 48 h until day 6. The cell culture supernatant

Formalin-fixed, paraffin-embedded sections (5 µm) of
human menstrual endometrium were deparaffinized in
xylene, rehydrated in an ethanol gradient, and then boiled

Flow Cytometry
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in antigen retrieval citrate-buffer (Vector Laboratories Inc.,
CA, United States). Subsequently, the samples were blocked
with 2.5% goat serum in PBS (Vector Laboratories) for 1 h
at room temperature. Sections were then incubated overnight
at 4◦ C with MBTD1 antibody (ab170848, Abcam) or normal
rabbit IgG (#2729, Cell Signaling Technology) diluted 1:50 in
2.5% normal goat serum. After washing with PBS, sections
were incubated with Alexa Fluor 488-conjugated secondary
antibody (Life Technologies) diluted 1:500 in 2.5% normal goat
serum for 1 h at room temperature. Thereafter, the sections were
washed with PBS (3 × 5 min each) and mounted with ProLong
Gold Antifade Mountant with DAPI (cat. no. P36962 Thermo
Scientific). Images were captured using a confocal microscope
(Leica DMI 4000B).

RESULTS
MBTD1 Expression Is Increased in
Stromal Cells of Secretory Phase
Endometrium
To explore the role of MBTD1 in endometrial function, we
took advantage of publicly available data sets to analyze MBTD1
expression in normal endometrium at various stages of the
menstrual cycle. We found a modest increase in the MBTD1 raw
expression score during the secretory phase of the menstrual cycle
as compared to the proliferative phase (Figure 1A, GSE4888)
(Talbi et al., 2006). Interestingly, MBTD1 raw expression score
was significantly reduced in the endometrium from women
with recurrent implantation failure compared to healthy women
(Figure 1B, GSE65102) (Lucas et al., 2016). These analyses
indicate that MBTD1 expression differs in women with and
without endometrial dysfunction. To determine where MBTD1
is expressed in the endometrium, we assessed MBTD1 protein
immunoreactivity in the endometrium from proliferative and
secretory phases (Figure 1C). We found an increased number of
MBTD1 stained cells in stroma of secretory phase endometrium
compared to proliferative phase endometrium (Figure 1C).
Rabbit IgG was used as an isotype control to ensure the specificity
of MBTD1 antibody (Figure 1D). These results suggest that
MBTD1 might play a role in endometrial decidualization, and
aberrant expression might be associated with uterine disorders
that affect fertility such as recurrent implantation failure. Given
this, in-depth functional analyses are warranted.

Immunocytochemistry
HESCs were grown on a coverslip coated with poly-L-lysine
(cat. no. P4832 Sigma-Aldrich) in six-well plates. After 6 days
of in vitro decidualization as described above, cells were fixed
with 4% paraformaldehyde (Alfa Aesar, United States) in PBS
for 20 min at room temperature. Cells were then washed three
times with PBS and permeabilized with 0.2% Triton X-100 (Sigma
Aldrich, United States) in PBS for 20 min at room temperature.
Next, cells were washed with PBS, blocked with 2.5% normal
goat serum (Vector Laboratories) in PBS for 1 h at room
temperature and incubated overnight at 4◦ C with anti-MBTD1
(ab170848, Abcam, 1:50 dilution) in 2.5% normal goat serum.
After washing with PBS, the cells were incubated with Alexa Fluor
488-conjugated secondary antibodies (Life Technologies, 1:500
dilution) for 1 h at room temperature, washed, and mounted
with ProLong Gold Antifade Mountant with DAPI (Thermo
Scientific). Images were captured with a confocal microscope
(Leica DMI 4000B) (Michalski et al., 2018).

MBTD1 Promotes Decidualization in
Transformed HESCs
Given that endometrial decidualization occurs during the
secretory phase of the menstrual cycle, and MBTD1 expression is
elevated in secretory phase endometrium, we questioned whether
MBTD1 has a role in endometrial decidualization. To test this,
we first used T-HESCs as a model for in vitro decidualization.
When exposed to decidualization conditions for 6 days, T-HESCs
exhibited a progressive increase in the expression of the decidual
marker prolactin (PRL) (Szwarc et al., 2018a; Figure 2A). By
day 6 of decidualization, T-HESCs also expressed over two-fold
more MBTD1 transcript than at day 0 (Figure 2A). Next, we
transfected the transformed HESCs with either control siRNA or
siRNA targeting MBTD1. As expected, control siRNA-transfected
cells transformed from fibroblastic to cobblestone-like epithelioid
cell morphology (Figure 2B) and showed increased expression
of PRL and MBTD1 by day 6 of decidualization (Figure 2C). In
contrast, cells transfected with MBTD1 siRNA failed to undergo
this morphological change (Figure 2B) and did not have elevated
expression of PRL or MBTD1 (Figure 2C). These results indicate
that MBTD1 promotes decidualization in transformed HESCs.

Mice and Hormone Treatments
All experimental procedures involving mice followed a
protocol approved by the Washington University in St.
Louis Institutional Animal Care and Use Committee (Protocol
Number 20160227). CD1 wild-type mice (Charles River, Saint
Louis, MO, United States) were maintained on a 12-h light:12-h
dark cycle. To assess uterine progesterone responses, 6-week-old
CD1 mice were bilaterally ovariectomized, allowed to rest
for 2 weeks to allow the endogenous ovarian-derived steroid
hormones to dissipate, and then subcutaneously injected with
100 µl of sesame oil (vehicle control) or 1 mg of progesterone
(Sigma-Aldrich) in 100 µl of sesame oil. Six hours later, mice
were euthanized, uterine tissues were collected, and RNA was
isolated and processed for qRT-PCR.

Statistical Analysis
A two-tailed paired Student’s t-test was used to analyze
experiments comparing two experimental groups, and analysis of
variance (ANOVA) by non-parametric alternatives was used for
multiple comparisons to analyze experiments containing more
than two groups. A value of p < 0.05 was considered significant.
All data are presented as mean ± SEM. GraphPad Prism 8
software was used for all statistical analyses.
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(Szwarc et al., 2018b) confirmed that the HESCs effectively
decidualized (Figure 3A). MBTD1 protein expression also
increased during decidualization, as evidenced both by Western
blot (Figure 3B) and by immunofluorescence (Figure 3C). These
data are in line with the elevated expression of stromal-derived
MBTD1 in secretory phase endometrium (Figure 1C). As
expected, MBTD1 protein was predominantly nuclear in both
non-decidualized and decidualized primary HESCs (Figure 3C).
The presence of MBTD1 in the non-decidualized cells is
consistent with its basal level expression in the proliferative
phase endometrium (Figure 1C).

MBTD1 Is Essential for Decidualization
of Primary HESCs
To determine whether MBTD1 was required for primary
HESC decidualization, we transfected HESCs with control
or MBTD1-targeting siRNAs and exposed the cells to
decidualization conditions. HESCs that received control
siRNA changed morphology (Figure 4A) and had increased
expression of MBTD1, IGFBP1, and PRL (Figure 4B) by
day 6. In contrast, HESCs that received MBTD1-targeting
siRNA did not show a dramatic morphological change
over 6 days (Figure 4A) and expressed significantly less
MBTD1, PRL, and IGFBP1 than control cells (Figure 4B).
Further, quantification of secreted Prolactin (PRL) from
culture media revealed the significant decrease at day 6 in
HESCs that received MBTD1-targeting siRNA (Figure 4C).
The knockdown efficiency of MBTD1 at protein level was
confirmed by immunoblotting (Figure 4D). As expected,
siRNA against MBTD1 effectively downregulated MBTD1
protein levels at both basal (day 0) and induced (day 6) time
points in decidualizing stromal cells. Together, these results
indicate that MBTD1 is required for complete primary HESC
decidualization.

MBTD1 Controls Cell Proliferation and
Cell Cycle Progression of Decidualizing
HESCs

FIGURE 1 | Endometrial expression of MBTD1 throughout the menstrual
cycle. (A) MBTD1 raw transcript scores of normal endometrium at various
phases of the menstrual cycle, from microarray analysis within a publicly
available GEO dataset (GSE4888). Results shown as mean ± SEM (n = 3–7).
P, proliferative; ES, early secretory; MS, mid-secretory; and LS, late secretory.
(B) MBTD1 raw transcript scores in the mid-secretory phase endometrium
from women with and without recurrent implantation failure (RIF) measured
from publicly available GEO data set (GSE65102) in patients. Results shown
as mean ± SEM (n = 10). (C) Immunolocalization of MBTD1 (green) in
proliferative and secretory phase endometrium (n = 9 proliferative and n = 6
secretory) showing increased nuclear localization in stromal cells of secretory
phase endometrium. White arrowheads indicate MBTD1-positive cells, and
red arrowheads indicate MBTD1-negative cells. Blue stain is DAPI. G, gland;
S, stroma. (D) Rabbit IgG was used as isotype control for staining. Scale bar:
100 µm, **P < 0.01 and ns, non-significant.

Given that stromal cell decidualization is regulated by many
factors that control cell cycle progression, we next examined
the effect of MBTD1 on cell cycle progression. To test this,
we transiently transfected HESCs with control siRNAs or
MBTD1 siRNA or PGR siRNA or MBTD1 and PGR siRNAs
together, cultured the cells for 48 h in EPC media, and
then subjected them to flow cytometry. Knockdown of
either MBTD1 or PGR resulted in an increase in G2/M
arrested cells, with a concomitant reduction in G0/G1 cells
(Figures 5A–E). Interestingly, we found no synergistic effect
of MBTD1 and PGR in mediating HESC proliferation.
The effect of PGR knockdown on G0/G1and G2/M is
consistent with published work (Logan et al., 2012) that
found MPA augments G2/M cell cycle arrest of HESCs during
decidualization. Since alterations in cell cycle progression
impacts cell survival, we next examined the effect of MBTD1
on stromal cell proliferation. Consistent with altered cell cycle
progression, we found that knockdown of either MBTD1

in transformed HESCs, MBTD1 transcripts increased by
6 days of decidualization in primary HESCs (Figure 3A).
Induction of the decidual markers PRL (Szwarc et al., 2018a)
and insulin-like growth factor-binding protein-1 (IGFBP1)
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FIGURE 2 | MBTD1 is required for decidualization of immortalized human endometrial stromal cells (HESCs). (A) Levels of PRL and MBTD1 transcripts from
immortalized HESCs after induction of decidualization over 6 days. (B) Representative images of transformed HESCs transfected with control or MBTD1 siRNA prior
to (day 0) and after 6 days of culture in decidualization (EPC, Estrogen-MPA-cAMP) conditions. Red arrowheads indicate non-decidualized cells, and black
arrowheads indicate decidualized cells. Scale bar: 200 µm. (C) Levels of MBTD1 and PRL transcripts in immortalized HESCs transfected with control or MBTD1
siRNA after 6 days of decidualization. Results are mean ± SEM from three biological replicates; **P < 0.01, ***P < 0.001, and ****P < 0.0001.

or PGR or both together resulted in a decreased HESC
proliferation (Figure 5F). Additionally, we confirmed the
effective knockdown of MBTD1 and PGR (Figure 5G) with
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FIGURE 3 | MBTD1 expression is induced during in vitro decidualization of primary human endometrial stromal cells (HESCs). (A) Levels of MBTD1, PRL, and
IGFBP1 transcripts from HESCs induced to decidualize for 6 days. (B) Western blot and densitometric analysis of MBTD1 protein levels from HESCs cultured in
decidualization media for 6 days. GAPDH was used as a loading control. (C) Immunofluorescent detection of MBTD1 (green) in HESCs treated with vehicle or
decidualization media (EPC, Estrogen-MPA-cAMP) prior to (day 0) and after decidualization (day 6). Prominent MBTD1 nuclear staining was apparent in decidualized
HESCs. Blue stain is DAPI. Red arrowhead indicates decidualized cells and blue arrowheads indicate non-decidualized cells. Scale bar: 100 µm. Results are shown
as the mean ± SEM from three biological replicates from a representative experiment (experiment repeated three times, n = 3); *P < 0.05, **P < 0.01, ***P < 0.001,
and ****P < 0.0001.
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FIGURE 4 | MBTD1 is essential for primary human endometrial stromal cell decidualization. (A) Morphology of human endometrial stromal cells (HESCs) transfected
with control or MBTD1 siRNA at basal (day 0) or after 6 days of culture in decidualization conditions. Red arrowheads indicate non-decidualized cells and black
arrowhead indicates decidualized cells. Scale bar: 200 µm. (B) Levels of MBTD1, IGFBP1, and PRL transcripts in HESCs transfected with control or MBTD1 siRNAs
at basal (day 0) or 6 days of decidualization. (C) Levels of secreted Prolactin into the media were measured using ELISA-based assay in HESCs transfected with
control or MBTD1 siRNAs at day 0 or 6 days after EPC treatment. (D) Western blot and densitometric analysis of MBTD1 protein levels from HESCs transfected with
control or MBTD1 siRNA. Representative data from three replicates from one patient sample are shown as mean ± SEM. The experiment was repeated three times,
n = 3; *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
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FIGURE 5 | MBTD1 controls human endometrial stromal cell proliferation and cell cycle progression. (A–D) Human endometrial stromal cells (HESCs) transfected
with control (A), MBTD1 (B), PGR (C), and PGR + MBTD1 siRNAs (D). After 48 h of transfection, cells were treated in decidualization media for 48 h and subjected
to flow cytometry analysis. Histograms depict the percentages of cells in each phase of the cell cycle. (E) Graph depicting the distribution of cells in indicated phases
of the cell cycle. (F) MTT cell proliferation assay of HESCs transfected with control siRNA or MBTD1 siRNA or PGR siRNA or MBTD1 + PGR siRNAs at indicated
time points. (G) Transcript levels of MBTD1 (left panel) and PGR (right panel) from HESCs after 48 h of transfection with indicated siRNAs. Representative data from
one patient sample and the experiment repeated three times with independent HES cell lines. Results represent the mean ± SEM (n = 3). *P < 0.05, **P < 0.01, ns,
non-significant.

(Figure 7A) and MBTD1 protein (Figure 7B) remained
unchanged in primary HESCs over 24 h of treatment with MPA.
Induction of the well-established PGR target FOXO1A at 4 h
post-MPA treatment confirmed that the cells responded to MPA
(Figure 7A). To determine the physiological relevance of this
finding, we measured Mbtd1 gene expression in uteri from
ovariectomized mice treated with progesterone (P4) for 6 h.
Although this treatment increased uterine expression of the wellestablished progesterone targets amphiregulin (Areg), Indian
hedgehog (Ihh), and interleukin 13 receptor subunit alpha 2
(Il13ra2) (Figure 7C; Kommagani et al., 2016; Rubel et al., 2016),
progesterone treatment did not increase expression of Mbtd1
(Figure 7C). Together, these data indicate that MBTD1 is not a
direct target of progesterone in human or murine endometrium.

MBTD1 Regulates Expression of
Progesterone Receptor Target Genes
To define the molecular mechanism by which MBTD1 promotes
decidualization, we evaluated the effect of MBTD1 knockdown
on expression of progesterone receptor (PGR) target genes
WNT4, FOXO1A, and GREB1, which together promote HESC
decidualization (Kommagani et al., 2016; Camden et al., 2017).
In primary HESCs, transfected with control siRNA, expression of
IGFBP1, PGR, WNT1, FOXO1A, and GREB1 all increased after
3 days in decidualization conditions (Figures 6A,B). Primary
HESCs transfected with MBTD1 siRNA had significantly less
IGFBP1, WNT4, FOXO1A, and GREB1 transcripts after 3 days
than did cells transfected with control siRNA (Figures 6A,B).
However, expression of PGR was not affected by MBTD1
knockdown in decidualizing HESCs (Figure 6A). These results
indicate that MBTD1 modulates PGR-mediated gene expression
but not PGR expression during endometrial decidualization.

DISCUSSION
In humans, endometrial stromal cell decidualization begins
spontaneously during the mid-secretory phase of the menstrual
cycle, even if a conceptus is not present (Zhang et al., 2013).
Successful endometrial stromal cell decidualization is one of
the critical events during early pregnancy and is required
for establishment of successful pregnancy. Increasing evidence

MBTD1 Is Not Responsive to
Progesterone in Human or Mouse
Endometrium
Finally, we wondered whether MBTD1 expression was regulated
by progesterone. The levels of both MBTD1 transcript
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FIGURE 6 | MBTD1 is required for induction of key decidual marker genes in decidualizing primary HESCs. (A) Transcript levels of MBTD1, IGFBP1, and PGR in
HESCs transfected with control or MBTD1 siRNAs and induced to decidualize for 3 days. (B) WNT4, FOXO1A, and GREB1 expression in HESCs transfected with
control or MBTD1 siRNAs and induced to decidualize for 3 days. Representative data from three replicates from one patient sample are shown as mean ± SEM. The
experiment repeated three times, n = 3; *P < 0.05, **P < 0.01, ***P < 0.001, ns, non-significant.

that MBTD1 mediates transcription of the PR targets WNT4,
FOXOA1, and GREB1. However, MBTD1 expression was not
regulated by progesterone.
We found that MBTD1 controls cell cycle progression
during stromal cell decidualization, which is consistent with
its established role in cell cycle regulation. For example, Luo
et al. (2013) showed that depletion of MBTD1 in oocytes
activated the cell cycle checkpoint protein Chk1 and led to
cell cycle arrest. Further, regulation of HESC proliferation by
MBTD1 is in line with published work that indicated that
MBTD1 controls growth of multiple cancer cells (de Rooij
et al., 2016; Hoang et al., 2018; Yamamoto et al., 2018; Fu
et al., 2019; Plesa and Sujobert, 2019; Wu et al., 2019). Thus,
based on our findings and published work, we posit that
MBTD1 functions in HESC decidualization through multiple
cellular mechanisms. First, MBTD1 could control the stromal
cell proliferation that precedes differentiation and cell cycle
progression of stromal cells to differentiate into decidual cells.
Second, MBTD1 could participate in protecting HESCs from
DNA damage. Recent reports indicate that DNA damage

suggests that impaired decidualization is the leading cause
in a variety of fertility-associated conditions including early
miscarriages, recurrent implantation failures (Salamonsen et al.,
2009; Wang and Yu, 2018; Messaoudi et al., 2019), recurrent
pregnancy loss, and preeclampsia (Brosens et al., 2002; Salker
et al., 2010). Specifically, impaired decidualization contributes to
∼30% of failed pregnancies and is a significant cause for recurrent
implantation failures in in vitro fertilization. Therefore, even with
high-quality embryo transfers, implantation failures occur due to
endometrial dysfunction.
Here, we provided five lines of evidence indicating that
MBTD1 participates in HESC decidualization by promoting
progesterone signaling. First, we showed that MBTD1 is
predominantly localized in the HESCs of secretory phase
endometrium. Second, MBTD1 expression was induced during
in vitro decidualization of both immortalized and primary
HESCs. Third, siRNA-mediated MBTD1 knockdown impaired
in vitro decidualization of both immortalized and primary
HESCs. Fourth, MBTD1 controls the HESC proliferation and
cell cycle progression during decidualization. Fifth, we showed
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FIGURE 7 | MBTD1 is not a progesterone-responsive gene in human or mouse endometrium. (A,B) Relative amounts of MBTD1 and FOXO1A mRNA (A) and
MBTD1 protein with densitometric analysis (B) in human endometrial stromal cells (HESCs) treated with 1 µM MPA over 24 h. Representative data from three
replicates from one patient sample are shown as mean ± SEM. GAPDH was used as a loading control. (C) The relative transcript levels of Areg (amphiregulin), Ihh
(Indian hedgehog), and Il13ra2 (interleukin 13 receptor subunit alpha 2) and Mbtd1 in uteri from ovariectomized mice treated with vehicle (oil) or 1 mg progesterone
(P4) for 6 h. Results represent the mean ± SEM; n = 5 mice/group. *P < 0.05, and ns, non-significant.

increases during decidualization (Lei et al., 2012). Specifically,
significantly higher levels of H2AX phosphorylation, a marker
of DNA damage, were observed at implantation sites compared
to inter-implantation sites in rodents (Lei et al., 2012; Yang
et al., 2018). Additionally, expression of the DNA damage repair

Frontiers in Cell and Developmental Biology | www.frontiersin.org

and DNA binding proteins is induced during the mid- to latesecretory phase of the menstrual cycle and is expressed in
decidualizing ESCs in vitro (Kajihara et al., 2006; Labied et al.,
2006). Furthermore, Luo et al. showed that depletion of MBTD1
in mouse oocytes led to downregulation of the DNA damage

11

August 2020 | Volume 8 | Article 745

Chadchan et al.

MBTD1 Role in Endometrial Decidualization

VM and GK assisted in select experiments and manuscript
writing and editing. RK conceived the project, supervised the
work, and provided resources. EJ assisted with obtaining donor
biopsies. All authors reviewed and approved the final version
of the manuscript.

repair checkpoint protein 53BP1 and increased formation of
γH2AX foci (Luo et al., 2013). Future work should investigate
the ability of MBTD1 to contribute to genomic stability during
decidualization.
Given the results presented here and the established roles of
MBTD1, we posit that MBTD1 enables progesterone-dependent
differentiation of HESCs into decidual cells. Further studies
investigating the role of MBTD1 in vivo will aid in developing
new diagnostics and therapeutics for endometrial pathologies
that affect fertility such as recurrent pregnancy loss.
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